Skip to content

Prospective, multicenter, single group target value method to evaluate the safety and efficacy of mechanical thrombectomy catheter in the treatment of acute iliofemoral deep venous thrombosis

Prospective, multicenter, single group target value method to evaluate the safety and efficacy of mechanical thrombectomy catheter in the treatment of acute iliofemoral deep venous thrombosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053270
Enrollment
Unknown
Registered
2021-11-18
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute iliofemoral deep venous thrombosis

Interventions

Experimental group:Mechanical thrombectomy catheter

Sponsors

The First Hospital of Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male or non pregnant or lactating female subjects aged 18 to 80 years; 2. Subjects diagnosed with acute iliofemoral deep venous thrombosis; 3. Subjects who can understand the purpose of the test, voluntarily participate in and sign informed consent, and are willing to follow up.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with pulmonary embolism; 2. The affected limb has a history of DVT; 3. Severe liver and kidney diseases (creatinine > 200 umol/L, ALT/AST > 3 x ULN or TBIL > 2 x ULN); 4. Active bleeding (severe gastric and duodenal ulcer); 5. Subjects with bleeding prone constitution (platelet count < 50 x 10^9/L); 6. Hemorrhagic stroke; 7. Severe hypertension; 8. Thrombolytic therapy in recent 1 month; 9. Subjects allergic to contrast media; 10. The guide wire cannot pass through the target lesion; 11. Intraoperative contrast vein diameter < 3 mm; 12. Subjects whose life expectancy is less than 12 months (such as advanced malignant tumor).

Design outcomes

Primary

MeasureTime frame
Thrombus clearance;Thrombus recurrence rate ;

Secondary

MeasureTime frame
Venous patency rate at 1, 6 and 12 months after operation;Incidence of postoperative complications (DVT related death, severe bleeding, clinical symptoms, pulmonary embolism) ;Incidence of post thrombotic syndrome ;Incidence of serious adverse events at 1, 6 and 12 months after operation;Incidence of device related adverse events ;

Countries

China

Contacts

Public ContactZou Yinghua

The First Hospital of Peking University

13801105222@139.com+86 10 83572211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026